How to remove the ‘What If’s’ from Cancer

Current cancer screenings are limited, only detecting a small number of cancers early. Many cancers are undetected and unchecked, left to their own destructive devices for far too long. Without effective early diagnosis, cancer can advance to later stages that require burdensome treatments resulting in uncertain, and often devastating, outcomes.

GRAIL is a biotechnology company that developed the Galleri™ multi-cancer early detection test.
By using advanced DNA sequencing-based technology with a single blood draw, Galleri™ efficiently uses one blood test to screen for over 50 cancers. By detecting most cancer types earlier, these results empower people to proactively protect their health.

GRAIL partnered with us to help establish and launch the Galleri™ test and encourage both patients and healthcare providers to check for cancer routinely. The goal was to raise awareness that this simple blood test is now an option and entice patients to request it from their physicians.

We developed a concept that focused on removing the various uncertainties around potentially having cancer. The Galleri test removes the ‘What ifs’. It has the potential to remove the questions around the possibility of having cancer. It can detect multiple types of cancer early and offer peace of mind.
We developed an animated video to explain the technology behind this test and the actual testing process itself. This helps both clinicians as well as patients better understand when this test should be used, what their results will look like, and what to do with them. This educational video helps patients and their providers understand the testing process and increase their comfort level, to ultimately diagnose and treat cancer as early as possible.